Enter your terms above and click the 'Search' button.

Showing articles 0 to 8 of 8 Filter Applied: MRI,serial (Click to remove) Infliximab for the Treatment of CNS Sarcoidosis Neurol 89:2092-2100, Gelfand, J.M.,et al, 2017 Hemorrhagic Manifestations of Reversible Cerebral Vasoconstriction Syndrome: Frequency, Features, and Risk Factors Stroke 41:2505-2511, 2455, Ducros,A.,et al, 2010 Natalizumab Plus Interferon Beta -1a for Relapsing Multiple Sclerosis NEJM 354:911-923,965, Rudick,R.A.,et al, 2006 A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis NEJM 354:899-910,965, Polman,C.H.,et al, 2006 Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis NEJM 355:1124-1140, Kappos,L.,et al, 2006 Evidence of Interferon B-1a Dose Response In Relapsing-Remitting MS, The OWIMS Study Neurol 53:679-686, The Once Weekly Interferon for MS Study Group (OWI, 1999 Linomide Reduces the Rate of Active Lesions in Relapsing-Remitting Multiple Sclerosis Neurol 47:895-900, Anderson,O.,et al, 1996 Neutralizing Antibodies During Treatment of Multiple Sclerosis with Interferon Beta-1b IFNB MS Study Group & UBC MS. MRI Analysis Group, Neurol 47:889-8946., , 1996 Showing articles 0 to 8 of 8